Aegerion Pharmaceuticals, Inc.
DelistedCIK 1338042fmd_1GQPNJY25TSYWB2YPD89F1A3DWManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2006 to Sep 30, 2016, 30 periods
Latest annual · FY2015
Millions- Operating income
- (45)
- Net income
- (73)
- Free cash flow
- 14
Latest quarter · Q3 FY2016
Millions- Operating income
- (19)
- Net income
- (27)
- Free cash flow
- (14)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2010 to FY2015
- n/m
Aegerion Pharmaceuticals, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2015 | FY2014 | Change | Source |
|---|---|---|---|---|
| Operating income | -$45.2 million | -$26.7 million | 10-K 2016-03-15 · proof | |
| Net income | -$73.3 million | -$39.4 million | 10-K 2016-03-15 · proof | |
| Cash from operating activities | $16 million | -$2.1 million | 10-K 2016-03-15 · proof | |
| Free cash flow | $14.1 million | -$6 million | 10-K 2016-03-15 · proof | |
| Total assets | $434.2 million | $412.4 million | +5.3% | 10-K 2016-03-15 · proof |
| Total liabilities | $318.7 million | $252.1 million | +26.4% | 10-K 2016-03-15 · proof |
| Cash and cash equivalents | $64.5 million | $375.9 million | -82.8% | 10-K 2016-03-15 · proof |
- What was Aegerion Pharmaceuticals, Inc.'s operating income in fiscal 2015?
- Aegerion Pharmaceuticals, Inc. reported operating income of -$45.2 million for fiscal 2015 (the year ended Dec 31, 2015), against -$26.7 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2016. SEC
- What was Aegerion Pharmaceuticals, Inc.'s net income in fiscal 2015?
- Aegerion Pharmaceuticals, Inc. reported net income of -$73.3 million for fiscal 2015 (the year ended Dec 31, 2015), against -$39.4 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2016. SEC
- What was Aegerion Pharmaceuticals, Inc.'s cash from operating activities in fiscal 2015?
- Aegerion Pharmaceuticals, Inc. reported cash from operating activities of $16 million for fiscal 2015 (the year ended Dec 31, 2015), against -$2.1 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2016. SEC
- What was Aegerion Pharmaceuticals, Inc.'s free cash flow in fiscal 2015?
- Aegerion Pharmaceuticals, Inc. reported free cash flow of $14.1 million for fiscal 2015 (the year ended Dec 31, 2015), against -$6 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2016. SEC
- What are Aegerion Pharmaceuticals, Inc.'s total assets?
- As of Dec 31, 2015, Aegerion Pharmaceuticals, Inc. reported total assets of $434.2 million, against $412.4 million a year earlier (+5.3%). Source: the 10-K filed with the SEC on Mar 15, 2016. SEC
- What are Aegerion Pharmaceuticals, Inc.'s total liabilities?
- As of Dec 31, 2015, Aegerion Pharmaceuticals, Inc. reported total liabilities of $318.7 million, against $252.1 million a year earlier (+26.4%). Source: the 10-K filed with the SEC on Mar 15, 2016. SEC
- What are Aegerion Pharmaceuticals, Inc.'s cash and cash equivalents?
- As of Dec 31, 2015, Aegerion Pharmaceuticals, Inc. reported cash and cash equivalents of $64.5 million, against $375.9 million a year earlier (-82.8%). Source: the 10-K filed with the SEC on Mar 15, 2016. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1338042&period_type=annual&limit=5"Information only, not investment advice.